BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8150100)

  • 1. Comparison of the efficacy of spironolactone versus flutamide in the treatment of hirsutism.
    Erenus M; Gürbüz O; Durmuşoğlu F; Demirçay Z; Pekin S
    Fertil Steril; 1994 Apr; 61(4):613-6. PubMed ID: 8150100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial.
    Cusan L; Dupont A; Gomez JL; Tremblay RR; Labrie F
    Fertil Steril; 1994 Feb; 61(2):281-7. PubMed ID: 8299783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions for hirsutism (excluding laser and photoepilation therapy alone).
    van Zuuren EJ; Fedorowicz Z; Carter B; Pandis N
    Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD010334. PubMed ID: 25918921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of spironolactone-oral contraceptive versus cyproterone acetate-estrogen regimens in the treatment of hirsutism.
    Erenus M; Yücelten D; Gürbüz O; Durmuşoğlu F; Pekin S
    Fertil Steril; 1996 Aug; 66(2):216-9. PubMed ID: 8690104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study.
    Karakurt F; Sahin I; Güler S; Demirbas B; Culha C; Serter R; Aral Y; Bavbek N
    Adv Ther; 2008 Apr; 25(4):321-8. PubMed ID: 18389188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the clinical efficacy and safety of flutamide versus flutamide plus an oral contraceptive in the treatment of hirsutism.
    Taner C; Inal M; Başogul O; Onoglu A; Karanfil C; Tinar S; Ispahi C
    Gynecol Obstet Invest; 2002; 54(2):105-8. PubMed ID: 12566753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of flutamide and cyproterone acetate in the treatment of hirsutism: a randomized controlled trial.
    Grigoriou O; Papadias C; Konidaris S; Antoniou G; Karakitsos P; Giannikos L
    Gynecol Endocrinol; 1996 Apr; 10(2):119-23. PubMed ID: 8701785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence rate of hirsutism after 3 different antiandrogen therapies.
    Yücelten D; Erenus M; Gürbüz O; Durmuşoğlu F
    J Am Acad Dermatol; 1999 Jul; 41(1):64-8. PubMed ID: 10411413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hirsutism in women with flutamide.
    Marcondes JA; Minnani SL; Luthold WW; Wajchenberg BL; Samojlik E; Kirschner MA
    Fertil Steril; 1992 Mar; 57(3):543-7. PubMed ID: 1531466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flutamide in the treatment of hirsutism: long-term clinical effects, endocrine changes, and androgen receptor behavior.
    Moghetti P; Castello R; Negri C; Tosi F; Magnani CM; Fontanarosa MC; Armanini D; Muggeo M
    Fertil Steril; 1995 Sep; 64(3):511-7. PubMed ID: 7641903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial.
    Moghetti P; Tosi F; Tosti A; Negri C; Misciali C; Perrone F; Caputo M; Muggeo M; Castello R
    J Clin Endocrinol Metab; 2000 Jan; 85(1):89-94. PubMed ID: 10634370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy of lower dose flutamide 125 mg/day in the treatment of hirsutism.
    Müderris II; Bayram F
    J Endocrinol Invest; 1999 Mar; 22(3):165-8. PubMed ID: 10219882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison between spironolactone and spironolactone plus finasteride in the treatment of hirsutism.
    Keleştimur F; Everest H; Unlühizarci K; Bayram F; Sahin Y
    Eur J Endocrinol; 2004 Mar; 150(3):351-4. PubMed ID: 15012621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hirsutism by finasteride and flutamide in women with polycystic ovary syndrome.
    Falsetti L; De Fusco D; Eleftheriou G; Rosina B
    Gynecol Endocrinol; 1997 Aug; 11(4):251-7. PubMed ID: 9272421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of a pure anti-androgen (flutamide) on LH, FSH, androgens and clinical status in idiopathic hirsutism.
    Couzinet B; Pholsena M; Young J; Schaison G
    Clin Endocrinol (Oxf); 1993 Aug; 39(2):157-62. PubMed ID: 8370128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged treatment of hirsutism with flutamide alone in patients affected by polycystic ovary syndrome.
    Pucci E; Genazzani AD; Monzani F; Lippi F; Angelini F; Gargani M; Barletta D; Luisi M; Genazzani AR
    Gynecol Endocrinol; 1995 Sep; 9(3):221-8. PubMed ID: 8540292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hirsutism--a low dose spironolactone therapy.
    Vĕtr M
    Acta Univ Palacki Olomuc Fac Med; 1989; 122():239-45. PubMed ID: 2530821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the clinical efficacy of flutamide and spironolactone plus Diane 35 in the treatment of idiopathic hirsutism: a randomized controlled study.
    Inal MM; Yildirim Y; Taner CE
    Fertil Steril; 2005 Dec; 84(6):1693-7. PubMed ID: 16359967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral androgen blockade versus glandular androgen suppression in the treatment of hirsutism.
    Carmina E; Lobo RA
    Obstet Gynecol; 1991 Nov; 78(5 Pt 1):845-9. PubMed ID: 1833685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of hirsutism with lowest-dose flutamide (62.5 mg/day).
    Müderris II; Bayram F; Güven M
    Gynecol Endocrinol; 2000 Feb; 14(1):38-41. PubMed ID: 10813105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.